1. Home
  2. APGE vs PHIN Comparison

APGE vs PHIN Comparison

Compare APGE & PHIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • PHIN
  • Stock Information
  • Founded
  • APGE 2022
  • PHIN 2023
  • Country
  • APGE United States
  • PHIN United States
  • Employees
  • APGE N/A
  • PHIN N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • PHIN
  • Sector
  • APGE Health Care
  • PHIN
  • Exchange
  • APGE Nasdaq
  • PHIN Nasdaq
  • Market Cap
  • APGE 2.4B
  • PHIN 2.0B
  • IPO Year
  • APGE 2023
  • PHIN N/A
  • Fundamental
  • Price
  • APGE $66.64
  • PHIN $53.46
  • Analyst Decision
  • APGE Strong Buy
  • PHIN Buy
  • Analyst Count
  • APGE 9
  • PHIN 5
  • Target Price
  • APGE $97.33
  • PHIN $57.20
  • AVG Volume (30 Days)
  • APGE 730.3K
  • PHIN 410.3K
  • Earning Date
  • APGE 11-10-2025
  • PHIN 10-28-2025
  • Dividend Yield
  • APGE N/A
  • PHIN 2.02%
  • EPS Growth
  • APGE N/A
  • PHIN N/A
  • EPS
  • APGE N/A
  • PHIN 2.18
  • Revenue
  • APGE N/A
  • PHIN $3,427,000,000.00
  • Revenue This Year
  • APGE N/A
  • PHIN $2.50
  • Revenue Next Year
  • APGE N/A
  • PHIN $1.55
  • P/E Ratio
  • APGE N/A
  • PHIN $24.46
  • Revenue Growth
  • APGE N/A
  • PHIN N/A
  • 52 Week Low
  • APGE $26.20
  • PHIN $36.25
  • 52 Week High
  • APGE $67.66
  • PHIN $59.88
  • Technical
  • Relative Strength Index (RSI)
  • APGE 73.22
  • PHIN 49.36
  • Support Level
  • APGE $61.81
  • PHIN $51.38
  • Resistance Level
  • APGE $67.66
  • PHIN $53.98
  • Average True Range (ATR)
  • APGE 3.73
  • PHIN 1.32
  • MACD
  • APGE 0.19
  • PHIN -0.01
  • Stochastic Oscillator
  • APGE 91.78
  • PHIN 50.37

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About PHIN PHINIA Inc.

Phinia Inc is engaged in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles, industrial applications, and light vehicles. Its product portfolio includes alternative fuel systems, fuel delivery modules, evaporative canisters, diesel fuel injection systems, electrical systems, hydrogen solutions, associated software, and others. The company's reportable segments are; the Fuel Systems segment, which derives key revenue, and the Aftermarket segment. Geographically, the company generates maximum revenue from the United States and the rest from the United Kingdom, China, Poland, Romania, Brazil, and other regions.

Share on Social Networks: